Sign in
Enrolling by invitationNo phase

Omega-3 supplement tested in women with polycystic ovary syndrome

Tests an omega-3 supplement against a placebo in women with polycystic ovary syndrome.

Key facts

Who runs it
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Where
Dhaka, BangladeshSee the site
Trial code
Registry title
Effect of Omega-3 Supplementation as Add on Therapy on Metabolic Syndrome in Women With Polycystic Ovary Syndrome.
Status
Enrolling by invitation
People taking part
68 people, planned
Started
22 Apr 2025
Planned end
30 Dec 2025
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Omega 3 fatty acids
  • Omega -3 fatty acids
Record updated
24 July 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for women with newly diagnosed polycystic ovary syndrome (PCOS). Half of the women get Omega-3 and half get a placebo for 3 months.

Age
Above 18 years up to 35 years (the registry lists 18 to 36 years).
Sex
Women only.
Disease stage
Newly diagnosed PCOS, meeting the Rotterdam criteria.
Earlier treatment
Cannot have taken Omega-3 supplements in the last three months.

Main reasons for not taking part

  • Pregnant or breastfeeding
  • History of diabetes (except if meeting metabolic syndrome criteria)
  • Any chronic illness such as liver, kidney or heart disease
  • Any acute or chronic infection or inflammatory disease
  • Known allergy to fish oil or Omega-3 supplements

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Age above 18 years up to 35 years
  • Newly diagnosed case of PCOS

Who cannot take part

  • Patients receiving Omega-3 supplementation within the last three months
  • History of diabetes mellitus (except those meeting metabolic syndrome criteria)
  • Any chronic illness (e.g. liver disease, kidney disease, cardiovascular disease)
  • Any acute or chronic infective or inflammatory disease
  • Exclusion of PCOS mimicking disease include hyperprolactinemia, adrenal hyperandrogenism, ovarian hyperandrogenism, cushing's syndrome, acromegaly etc
  • Known allergy to fish oil or Omega-3 supplements

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 36 years old?

Where in Bangladesh

  • Fariba kabirDhaka, BangladeshEnrolling by invitation

About the trial

What the trial wants to find out

The goal of this clinical trial is to learn if Omega-3 works to treat Polycystic ovary syndrome in women. It will also learn about the safety of drug Omega-3. The main questions it aims to answer are:

Read full original descriptionShow less

Does Omega-3 lower the number of times participant to treat metabolic syndrome What medical problems do participants have when taking drug Omega-3.Researchers will compare drug Omega-3 to a placebo (a look-alike substance that contains no drug) to see if drug Omega-3 used to treat PCOS.

Participants will:

Take Omega-3 or a placebo every day for 3 months Visit the clinic once every 6 weeks for checkups and tests Keep a diary of their symptoms and menstrual history.

The 2 groups in the trial

  • Omega-3Treatment being tested

    Participants received Omega-3 1gm tablet orally twice daily for 12 weeks.

    Treatment: Omega 3 fatty acids and Omega -3 fatty acids

  • placeboPlacebo, for comparison

    Participants received Omega-3 1gm placebo matching Omega-3 tablet orally twice daily for 12 weeks

    Treatment: Omega 3 fatty acids and Omega -3 fatty acids

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Effect of Omega-3 Supplementation as Add on Therapy on Metabolic Syndrome in Women With Polycystic Ovary Syndrome: A Randomized Double-Blind, Placebo-Controlled Trial
Plain-language title
Omega-3 supplement tested in women with polycystic ovary syndromeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT07036952, who can take part
Record updated
24 July 2025